Myriad Genetics Kicks Off TV Ad/Awareness Campaign for BRCA Cancer Risk | GenomeWeb
NEW YORK (GenomeWeb News) — Myriad Genetics this week launched an advertising campaign in certain regions of the US aimed at educating women about the genetic risks of developing breast and ovarian cancers and selling its BRACAnalysis tests.
Myriad Genetics said it hopes its so-called BRACAnalysis Awareness Campaign, which will include television spots, will make more women aware of the genetic links to cancer, and get them to consult a physician or seek genetic counseling to find out if they should order the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.